Logo image of HCTI

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

NASDAQ:HCTI - Nasdaq - US42227W2070 - Common Stock - Currency: USD

3.9011  +0.6 (+18.22%)

Fundamental Rating

2

Overall HCTI gets a fundamental rating of 2 out of 10. We evaluated HCTI against 35 industry peers in the Health Care Technology industry. While HCTI seems to be doing ok healthwise, there are quite some concerns on its profitability. HCTI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HCTI has reported negative net income.
In the past year HCTI has reported a negative cash flow from operations.
HCTI had negative earnings in 4 of the past 5 years.
HCTI had a negative operating cash flow in each of the past 5 years.
HCTI Yearly Net Income VS EBIT VS OCF VS FCFHCTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

With a Return On Assets value of -49.27%, HCTI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -67.70%, HCTI is doing worse than 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -49.27%
ROE -67.7%
ROIC N/A
ROA(3y)-159.11%
ROA(5y)-96.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCTI Yearly ROA, ROE, ROICHCTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

The Gross Margin of HCTI (19.53%) is worse than 77.14% of its industry peers.
In the last couple of years the Gross Margin of HCTI has grown nicely.
HCTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y3.95%
HCTI Yearly Profit, Operating, Gross MarginsHCTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

5

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCTI has more shares outstanding
HCTI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HCTI has a worse debt to assets ratio.
HCTI Yearly Shares OutstandingHCTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
HCTI Yearly Total Debt VS Total AssetsHCTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

HCTI has an Altman-Z score of 248.30. This indicates that HCTI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 248.30, HCTI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
HCTI has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, HCTI is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 248.3
ROIC/WACCN/A
WACC10.59%
HCTI Yearly LT Debt VS Equity VS FCFHCTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

HCTI has a Current Ratio of 3.07. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.07, HCTI is doing good in the industry, outperforming 68.57% of the companies in the same industry.
A Quick Ratio of 3.07 indicates that HCTI has no problem at all paying its short term obligations.
HCTI has a better Quick ratio (3.07) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
HCTI Yearly Current Assets VS Current LiabilitesHCTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

HCTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.11%, which is quite impressive.
Looking at the last year, HCTI shows a very negative growth in Revenue. The Revenue has decreased by -58.91% in the last year.
The Revenue for HCTI have been decreasing by -16.46% on average. This is quite bad
EPS 1Y (TTM)65.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.68%
Revenue 1Y (TTM)-58.91%
Revenue growth 3Y-30.78%
Revenue growth 5Y-16.46%
Sales Q2Q%-9.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCTI Yearly Revenue VS EstimatesHCTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 20M 40M 60M
HCTI Yearly EPS VS EstimatesHCTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCTI Price Earnings VS Forward Price EarningsHCTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCTI Per share dataHCTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (8/15/2025, 3:59:01 PM)

3.9011

+0.6 (+18.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15 2023-05-15/amc
Earnings (Next)N/A N/A
Inst Owners0.24%
Inst Owner Change70.5%
Ins Owners0.01%
Ins Owner Change-13.3%
Market Cap1.59B
Analysts82.86
Price TargetN/A
Short Float %0.8%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 141.12
P/FCF N/A
P/OCF N/A
P/B 185.78
P/tB 185.78
EV/EBITDA N/A
EPS(TTM)-227.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.03
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.27%
ROE -67.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.53%
FCFM N/A
ROA(3y)-159.11%
ROA(5y)-96.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y3.95%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z 248.3
F-Score3
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.91%
Revenue growth 3Y-30.78%
Revenue growth 5Y-16.46%
Sales Q2Q%-9.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.47%
OCF growth 3YN/A
OCF growth 5YN/A